Literature DB >> 12960174

TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.

Brenda J Irvin1, Lauren D Wood, Lilin Wang, Randy Fenrick, Courtney G Sansam, Graham Packham, Michael Kinch, Elizabeth Yang, Scott W Hiebert.   

Abstract

The ETS family transcriptional repressor TEL is frequently disrupted by chromosomal translocations, including the t(12;21) in which the second allele of TEL is deleted in up to 90% of the cases. Consistent with its role as a putative tumor suppressor, TEL expression inhibits colony formation by Ras-transformed NIH 3T3 cells and hinders proliferation of a variety of cell types. Although we observed no alteration in the cell cycle of TEL-expressing cells, we did find a marked increase in apoptosis of serum-starved TEL-expressing NIH 3T3 cells. This decrease in cell survival required the DNA binding domain of TEL, suggesting that TEL repressed an anti-apoptotic gene. These observations prompted us to search for genes regulated by ETS family proteins that regulate apoptosis. The anti-apoptotic molecule Bcl-XL contains multiple ets-factor binding sites within its promoters, and TEL repressed a Bcl-XL promoter-linked reporter gene. Moreover, the enforced expression of TEL decreased the endogenous expression of both Bcl-XL mRNA and protein. TEL-mediated repression of Bcl-XL likely affects cell survival via regulation of the apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960174     DOI: 10.1074/jbc.M305189200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  ETV6 in hematopoiesis and leukemia predisposition.

Authors:  Hanno Hock; Akiko Shimamura
Journal:  Semin Hematol       Date:  2017-04-07       Impact factor: 3.851

2.  Transcription Factor Ets-2 Acts as a Preinduction Repressor of Interleukin-2 (IL-2) Transcription in Naive T Helper Lymphocytes.

Authors:  Ioannis Panagoulias; Tassos Georgakopoulos; Ioanna Aggeletopoulou; Marios Agelopoulos; Dimitris Thanos; Athanasia Mouzaki
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

3.  DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.

Authors:  Sean M Green; H Jerome Coyne; Lawrence P McIntosh; Barbara J Graves
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

4.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.

Authors:  Xiaobo Cao; James Littlejohn; Charles Rodarte; Lidong Zhang; Benjamin Martino; Philip Rascoe; Kamran Hamid; Daniel Jupiter; W Roy Smythe
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

6.  CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia.

Authors:  Benjamin Neveu; Jean-François Spinella; Chantal Richer; Karine Lagacé; Pauline Cassart; Mathieu Lajoie; Silvana Jananji; Simon Drouin; Jasmine Healy; Gilles R X Hickson; Daniel Sinnett
Journal:  Haematologica       Date:  2016-08-18       Impact factor: 9.941

7.  Autoinhibition of ETV6 (TEL) DNA binding: appended helices sterically block the ETS domain.

Authors:  H Jerome Coyne; Soumya De; Mark Okon; Sean M Green; Niraja Bhachech; Barbara J Graves; Lawrence P McIntosh
Journal:  J Mol Biol       Date:  2012-05-12       Impact factor: 5.469

8.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.